Adiponectin predicts 5-year all cause in patients with symptomatic peripheral arterial disease: Results from the Linz Peripheral Arterial Disease (LIPAD) study

被引：0
|
作者：
Dieplinger, B. [1 ]
Gegenhuber, A. [2 ]
Poelz, W. [3 ]
Haltmayer, M. [1 ]
Mueller, T. [1 ]
机构：
[1] Konvent Hosp Barmherzige Brueder, Linz, Austria
[2] Krankenhaus Bad Ischl, Bad Ischl, Austria
[3] Univ Linz, A-4040 Linz, Austria
来源：
EUROPEAN HEART JOURNAL | 2009年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
  • [21] The association of relative telomere length with symptomatic peripheral arterial disease: Results from the CAVASIC study
    Raschenberger, Julia
    Kollerits, Barbara
    Hammerer-Lercher, Angelika
    Rantner, Barbara
    Stadler, Marietta
    Haun, Margot
    Klein-Weigel, Peter
    Fraedrich, Gustav
    Kronenberg, Florian
    ATHEROSCLEROSIS, 2013, 229 (02) : 469 - 474
  • [22] Increased pregnancy-associated plasma protein-a as a marker for peripheral atherosclerosis: Results from the Linz peripheral arterial disease study
    Mueller, Thomas
    Dieplingerl, Benjamin
    Poelz, Werner
    Haltmayer, Meinhard
    CLINICAL CHEMISTRY, 2006, 52 (06) : 1096 - 1103
  • [23] Peripheral Arterial Disease as an Independent Predictor for Excess Cerebrovascular Mortality in Primary Care Patients: 5-year Results of the getABI Study.
    Haberl, Roman L.
    Meves, Saskia
    Diehm, Curt
    Allenberg, Jens-R
    Darius, Harald
    Mahn, Matthias
    Pittrow, David
    Endres, Heinz G.
    Tepohl, Gerhart
    Trampisch, Hans-Joachim
    Berger, Klaus
    STROKE, 2009, 40 (04) : E188 - E189
  • [24] ADMA (ASYMMETRIC DIMETHYLARGININE) PREDICTS ALL-CAUSE MORTALITY AND CARDIOVASCULAR EVENTS IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE: THE GETABI STUDY
    Anderssohn, M.
    Boeger, R. H.
    Endres, H. G.
    Schwedhelm, E.
    Darius, H.
    Atzler, D.
    Lueneburg, N.
    von Stritzky, B.
    Maas, R.
    Thiem, U.
    Benndorf, R. A.
    Diehm, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 52 - 53
  • [25] Serum Lipoprotein (A) and Symptomatic Peripheral Arterial Disease in Diabetic Patients
    Rehman, Atta U. R.
    Dastagir, Iram
    Akbar, Ruhina
    Farooq, Muhammad
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2015, 9 (01): : 197 - 199
  • [26] Skin Autofluorescence, 5-Year Mortality, and Cardiovascular Events in Peripheral Arterial Disease All That Glitters Is Surely Not Gold
    Schmidt, Ann Marie
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34 (04) : 697 - 699
  • [27] Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD)
    Shigematsu, H.
    Nishibe, T.
    Obitsu, Y.
    Matsuzaki, K.
    Ishida, A.
    Miyata, T.
    Shindo, S.
    Hida, K.
    Ohta, T.
    Ando, M.
    Kawasaki, T.
    Yasugi, T.
    Matsumoto, T.
    INTERNATIONAL ANGIOLOGY, 2010, 29 (02) : 2 - 13
  • [28] DIAGNOSIS AND 5-YEAR PROGNOSIS OF SILENT ISCHEMIC-HEART-DISEASE IN 418 PATIENTS WITH PERIPHERAL ARTERIAL-DISEASE
    PONSONNAILLE, J
    FABRY, R
    CHAPOU, M
    LIPIECKI, J
    DELAHAYE, R
    DUCHENEMARULLAZ, P
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1991, 84 (10): : 1407 - 1411
  • [29] Predictors of Mortality in Patients with Lower Extremity Peripheral Arterial Disease: 5-Year Follow-up
    Jaffery, Zehra
    Greenbaum, Adam B.
    Siddiqui, Mohammad F.
    Mahendraker, Neetu
    Gupta, Vikesh
    Mokkala, Vidu
    Kanakadandi, Uday
    Robbins, Andrew
    Mccord, James
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2009, 22 (06) : 564 - 570
  • [30] Outcomes of hybrid procedures for peripheral arterial disease: 5-year single center experience
    Gonzalez-De Leo, Stefany
    Montbriand, Janice
    Eisenberg, Naomi
    Roche-Nagle, Graham
    CIRUGIA Y CIRUJANOS, 2022, 90 (05): : 610 - 616
12345